{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:26:25Z","timestamp":1791483985426,"version":"4.3.4"},"update-to":[{"DOI":"10.1371\/journal.pmed.1004102","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000}}],"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:p>\n                    <jats:list list-type=\"bullet\">\n                      <jats:list-item>\n                        <jats:p>UNAIDS and a broad range of partners have collaborated to establish a new set of HIV prevention targets to be achieved by 2025 as an intermediate step towards the sustainable development target for 2030.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>The number of new HIV infections in the world continues to decline, in part due to the extraordinary expansion of effective HIV treatment. However, the decline is geographically heterogeneous, with some regions reporting a rise in incidence. The incidence target that was agreed for 2020 has been missed.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>A range of exciting new HIV prevention technologies have become available or are in the pipeline but will only have an impact if they are accessible and affordable and delivered within systems that take full account of the social and political context in which most infections occur. Most new infections occur in populations that are marginalised or discriminated against due to structural, legal, and cultural barriers.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>The new targets imply a new approach to HIV prevention that emphasises appropriate, person-centred, prioritised, effective, combination HIV prevention within a framework that reduces existing barriers to services and acknowledges heterogeneity, autonomy, and choice.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>These targets have consequences for people working in HIV programmes both for delivery and for monitoring and evaluation, for health planners setting local and national priorities, and for funders both domestic and global. Most importantly, they have consequences for people who are at risk of HIV exposure and infection.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Achieving these targets will have a huge impact on the future of the HIV epidemic and put us back on track towards ending AIDS as a public health threat by 2030.<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:p>","DOI":"10.1371\/journal.pmed.1004102","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T13:52:37Z","timestamp":1664200357000},"page":"e1004102","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["HIV prevention for the next decade: Appropriate, person-centred, prioritised, effective, combination prevention"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5929-9524","authenticated-orcid":true,"given":"Peter","family":"Godfrey-Faussett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Frescura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quarraisha","family":"Abdool Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Ghys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"(on behalf of the 2025 prevention targets working group)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"key":"pmed.1004102.ref001","unstructured":"United Nations, Department of Economic and Social Affairs. Ensure healthy lives and promote well-being for all at all ages. [cited 2022 Jul 17] Available from: https:\/\/sdgs.un.org\/goals\/goal3."},{"issue":"6","key":"pmed.1004102.ref002","doi-asserted-by":"crossref","first-page":"e1003649","DOI":"10.1371\/journal.pmed.1003649","article-title":"Ending AIDS as a public health threat by 2030: Time to reset targets for 2025","volume":"18","author":"PR De Lay","year":"2021","journal-title":"PLoS Med"},{"key":"pmed.1004102.ref003","unstructured":"UNAIDS. Global AIDS Strategy 2021\u20132026. [cited 2022 Jul 17] Available from: https:\/\/www.unaids.org\/en\/resources\/documents\/2021\/2021-2026-global-AIDS-strategy."},{"key":"pmed.1004102.ref004","unstructured":"UNAIDS. 2014 Fast Track Targets. [cited 2022 Jul 17] Available from: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/JC2686_WAD2014report_en.pdf."},{"key":"pmed.1004102.ref005","author":"UNAIDS","year":"2021","journal-title":"Global AIDS Update"},{"issue":"10189","key":"pmed.1004102.ref006","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/S0140-6736(19)30418-0","article-title":"Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study","volume":"393","author":"AJ Rodger","year":"2019","journal-title":"Lancet"},{"issue":"8","key":"pmed.1004102.ref007","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3018(18)30132-2","article-title":"Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study","volume":"5","author":"BR Bavinton","year":"2018","journal-title":"Lancet HIV"},{"issue":"27","key":"pmed.1004102.ref008","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"RM Grant","year":"2010","journal-title":"N Engl J Med"},{"issue":"23","key":"pmed.1004102.ref009","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection","volume":"373","author":"JM Molina","year":"2015","journal-title":"N Engl J Med"},{"issue":"8","key":"pmed.1004102.ref010","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/OLQ.0000000000001187","article-title":"Trends in Human Immunodeficiency Virus and Sexually Transmitted Infection Testing Among Gay, Bisexual, and Other Men Who Have Sex With Men After Rapid Scale-up of Preexposure Prophylaxis in Victoria, Australia","volume":"47","author":"KE Ryan","year":"2020","journal-title":"Sex Transm Dis"},{"issue":"7","key":"pmed.1004102.ref011","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2101016","article-title":"Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women","volume":"385","author":"RJ Landovitz","year":"2021","journal-title":"N Engl J Med"},{"issue":"10337","key":"pmed.1004102.ref012","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(22)00538-4","article-title":"Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial","volume":"399","author":"S Delany-Moretlwe","year":"2022","journal-title":"Lancet"},{"issue":"22","key":"pmed.1004102.ref013","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","article-title":"Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women","volume":"375","author":"A Nel","year":"2016","journal-title":"N Engl J Med"},{"issue":"22","key":"pmed.1004102.ref014","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","article-title":"Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women","volume":"375","author":"JM Baeten","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"pmed.1004102.ref015","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/s41467-019-09139-4","article-title":"Inferring HIV-1 transmission networks and sources of epidemic spread in Africa with deep-sequence phylogenetic analysis","volume":"10","author":"O Ratmann","year":"2019","journal-title":"Nat Commun"},{"issue":"Suppl 5","key":"pmed.1004102.ref016","doi-asserted-by":"crossref","first-page":"e25788","DOI":"10.1002\/jia2.25788","article-title":"Naomi: a new modelling tool for estimating HIV epidemic indicators at the district level in sub-Saharan Africa","volume":"24","author":"JW Eaton","year":"2021","journal-title":"J Int AIDS Soc"},{"key":"pmed.1004102.ref017","unstructured":"Hall M, Golubchik T, Bonsall D, <Abeler-D\u00f6rner L, Limbada M, Kosloff B, et al. On behalf of the HPTN 071 (PopART) Phylogenetics protocol team and the PANGEA protocol team. Demographic characteristics of sources of HIV-1 transmission in Zambia [preprint]. [cited 2022 Jul 17] Available from: https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2021\/10\/07\/2021.10.04.21263560.full.pdf."},{"key":"pmed.1004102.ref018","unstructured":"UNAIDS. 90-90-90 Treatment Target. [cited 2022 Jul 17] Available from: https:\/\/www.unaids.org\/en\/90-90-90."},{"issue":"8","key":"pmed.1004102.ref019","doi-asserted-by":"crossref","first-page":"e0272405","DOI":"10.1371\/journal.pone.0272405","article-title":"Achieving the 95 95 95 targets for all: A pathway to ending AIDS","volume":"17","author":"L Frescura","year":"2022","journal-title":"PLoS ONE"},{"issue":"7","key":"pmed.1004102.ref020","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1016\/S2352-3018(16)30062-5","article-title":"The HIV prevention cascade: more smoke than thunder?","volume":"3","author":"P. Godfrey-Faussett","year":"2016","journal-title":"Lancet HIV"},{"issue":"8","key":"pmed.1004102.ref021","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/09540121.2019.1698703","article-title":"Enhancers and barriers to uptake of male circumcision services in Northern Uganda: a qualitative study","volume":"32","author":"BM Nanteza","year":"2020","journal-title":"AIDS Care"},{"issue":"5","key":"pmed.1004102.ref022","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10461-019-02407-w","article-title":"Application of an HIV Prevention Cascade to Identify Gaps in Increasing Coverage of Voluntary Medical Male Circumcision Services in 42 Rural Zambian Communities","volume":"23","author":"B Hensen","year":"2019","journal-title":"AIDS Behav"},{"issue":"8","key":"pmed.1004102.ref023","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/OLQ.0000000000001020","article-title":"Sex Worker Community-led Interventions Interrupt Sexually Transmitted Infection\/Human Immunodeficiency Virus Transmission and Improve Human Immunodeficiency Virus Cascade Outcomes: A Program Review from South India","volume":"46","author":"S Reza-Paul","year":"2019","journal-title":"Sex Transm Dis"},{"issue":"7","key":"pmed.1004102.ref024","doi-asserted-by":"crossref","first-page":"e720","DOI":"10.1016\/S2214-109X(17)30198-5","article-title":"Innovative financing instruments for global health 2002\u201315: a systematic analysis","volume":"5","author":"R Atun","year":"2017","journal-title":"Lancet Glob Health"},{"key":"pmed.1004102.ref025","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/QAD.0000000000002797","article-title":"Increasing preexposure prophylaxis use and \u2018net prevention coverage\u2019 in behavioural surveillance of Australian gay and bisexual men","volume":"35","author":"M Holt","year":"2021","journal-title":"AIDS"},{"issue":"Suppl 4","key":"pmed.1004102.ref026","doi-asserted-by":"crossref","first-page":"e25318","DOI":"10.1002\/jia2.25318","article-title":"Reaching and targeting more effectively: the application of market segmentation to improve HIV prevention programmes","volume":"22","author":"A Gomez","year":"2019","journal-title":"J Int AIDS Soc"},{"issue":"10","key":"pmed.1004102.ref027","doi-asserted-by":"crossref","first-page":"e25827","DOI":"10.1002\/jia2.25827","article-title":"HIV PrEP is more than ART-lite: Longitudinal study of real-world PrEP services data identifies missing measures meaningful to HIV prevention programming","volume":"24","author":"JB Reed","year":"2021","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"pmed.1004102.ref028","doi-asserted-by":"crossref","first-page":"e0212271","DOI":"10.1371\/journal.pone.0212271","article-title":"\u201cI am still negative\u201d: Female sex workers\u2019 perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa","volume":"14","author":"R Eakle","year":"2019","journal-title":"PLoS ONE"},{"issue":"4 Suppl 3","key":"pmed.1004102.ref029","doi-asserted-by":"crossref","first-page":"20227","DOI":"10.7448\/IAS.18.4.20227","article-title":"Rethinking HIV prevention to prepare for oral PrEP implementation for young African women","volume":"18","author":"CL Celum","year":"2015","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"pmed.1004102.ref030","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/S2352-3018(22)00029-7","article-title":"Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study","volume":"9","author":"AN Phillips","year":"2022","journal-title":"Lancet HIV"},{"issue":"25","key":"pmed.1004102.ref031","doi-asserted-by":"crossref","first-page":"30553","DOI":"10.2807\/1560-7917.ES.2017.22.25.30553","article-title":"Fall in new HIV diagnoses among men who have sex with men (MSM) at selected London sexual health clinics since early 2015: testing or treatment or pre-exposure prophylaxis (PrEP)?","volume":"22","author":"AE Brown","year":"2017","journal-title":"Euro Surveill"},{"issue":"11","key":"pmed.1004102.ref032","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.1016\/S2352-3018(18)30215-7","article-title":"Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study","volume":"5","author":"AE Grulich","year":"2018","journal-title":"Lancet HIV"},{"issue":"11","key":"pmed.1004102.ref033","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1089\/apc.2021.0064","article-title":"Are We Hitting the Target? HIV Pre-Exposure Prophylaxis from 2012 to 2020 in the OPERA Cohort","volume":"35","author":"KC Mounzer","year":"2021","journal-title":"AIDS Patient Care STDs"},{"issue":"383","key":"pmed.1004102.ref034","doi-asserted-by":"crossref","first-page":"eaag0019","DOI":"10.1126\/scitranslmed.aag0019","article-title":"Using geospatial mapping to design HIV elimination strategies for sub-Saharan Africa","volume":"9","author":"BJ Coburn","year":"2017","journal-title":"Sci Transl Med"},{"key":"pmed.1004102.ref035","unstructured":"UNAIDS. HIV sub-national estimates viewer. [cited 2022 Jul 17] Available from: https:\/\/naomi-spectrum.unaids.org\/."},{"issue":"9","key":"pmed.1004102.ref036","doi-asserted-by":"crossref","first-page":"e25390","DOI":"10.1002\/jia2.25390","article-title":"The impact, cost and cost-effectiveness of oral pre-exposure prophylaxis in sub-Saharan Africa: a scoping review of modelling contributions and way forward","volume":"22","author":"KK Case","year":"2019","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"pmed.1004102.ref037","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/QAI.0000000000002436","article-title":"Age-Specific Risk Scores Do Not Improve HIV-1 Prediction Among Women in South Africa","volume":"85","author":"K Peebles","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"pmed.1004102.ref038","doi-asserted-by":"crossref","first-page":"e025122","DOI":"10.1136\/bmjopen-2018-025122","article-title":"PrEP Implementation for Mothers in Antenatal Care (PrIMA): study protocol of a cluster randomised trial","volume":"9","author":"JC Dettinger","year":"2019","journal-title":"BMJ Open"},{"issue":"2","key":"pmed.1004102.ref039","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S2352-3018(16)30190-4","article-title":"Swaziland HIV Incidence Measurement Survey (SHIMS): a prospective national cohort study","volume":"4","author":"J Justman","year":"2017","journal-title":"Lancet HIV"},{"issue":"10","key":"pmed.1004102.ref040","doi-asserted-by":"crossref","first-page":"e25826","DOI":"10.1002\/jia2.25826","article-title":"Association between HIV PrEP indications and use in a national sexual network study of US men who have sex with men","volume":"24","author":"KM Weiss","year":"2021","journal-title":"J Int AIDS Soc"},{"issue":"9962","key":"pmed.1004102.ref041","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(14)60931-4","article-title":"Global epidemiology of HIV among female sex workers: influence of structural determinants","volume":"385","author":"K Shannon","year":"2015","journal-title":"Lancet"},{"issue":"9","key":"pmed.1004102.ref042","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/0956462420932424","article-title":"Falling HIV incidence in a community clinic cohort of men who have sex with men and transgender women in Barcelona, Spain","volume":"31","author":"M Meulbroek","year":"2020","journal-title":"Int J STD AIDS"},{"issue":"1","key":"pmed.1004102.ref043","doi-asserted-by":"crossref","first-page":"e1003482","DOI":"10.1371\/journal.pmed.1003482","article-title":"Estimating HIV pre-exposure prophylaxis need and impact in Malawi, Mozambique and Zambia: A geospatial and risk-based analysis","volume":"18","author":"D Stelzle","year":"2021","journal-title":"PLoS Med"},{"key":"pmed.1004102.ref044","doi-asserted-by":"crossref","first-page":"102894","DOI":"10.1016\/j.ebiom.2020.102894","article-title":"Single oral dose for HIV pre or post-exposure prophylaxis: user desirability and biological efficacy in macaques","volume":"58","author":"I Massud","year":"2020","journal-title":"EBioMedicine"},{"issue":"10","key":"pmed.1004102.ref045","doi-asserted-by":"crossref","first-page":"e25818","DOI":"10.1002\/jia2.25818","article-title":"Declining HIV incidence in sub-Saharan Africa: a systematic review and meta-analysis of empiric data","volume":"24","author":"K Joshi","year":"2021","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"pmed.1004102.ref046","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1186\/s12913-019-4691-z","article-title":"Satisfaction with use of public health and peer-led facilities for HIV prevention services by key populations in Nigeria","volume":"19","author":"B Ochonye","year":"2019","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"pmed.1004102.ref047","first-page":"e0264249","article-title":"Removing the societal and legal impediments to the HIV response: an evidence-based framework for 2025 and beyond PLoS ONE","volume":"17","author":"AL Stangl","year":"2022"},{"issue":"11","key":"pmed.1004102.ref048","doi-asserted-by":"crossref","first-page":"e1003836","DOI":"10.1371\/journal.pmed.1003836","article-title":"UNAIDS Expert Group on Integration Integrating HIV services and other health services: A systematic review and meta-analysis","volume":"18","author":"CA Bulstra","year":"2021","journal-title":"PLoS Med"},{"issue":"5","key":"pmed.1004102.ref049","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/13625187.2018.1508650","article-title":"A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV","volume":"23","author":"B Young Holt","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"10","key":"pmed.1004102.ref050","doi-asserted-by":"crossref","first-page":"e1003831","DOI":"10.1371\/journal.pmed.1003831","article-title":"Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030","volume":"18","author":"J Stover","year":"2021","journal-title":"PLoS Med"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1004102","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000}},{"DOI":"10.1371\/journal.pmed.1004131","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T14:21:28Z","timestamp":1701094888000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004102","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]}}}